Vladimı́r Leksa

667 total citations
24 papers, 479 citations indexed

About

Vladimı́r Leksa is a scholar working on Molecular Biology, Immunology and Immunology and Allergy. According to data from OpenAlex, Vladimı́r Leksa has authored 24 papers receiving a total of 479 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 8 papers in Immunology and 7 papers in Immunology and Allergy. Recurrent topics in Vladimı́r Leksa's work include Cell Adhesion Molecules Research (7 papers), Protease and Inhibitor Mechanisms (6 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (4 papers). Vladimı́r Leksa is often cited by papers focused on Cell Adhesion Molecules Research (7 papers), Protease and Inhibitor Mechanisms (6 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (4 papers). Vladimı́r Leksa collaborates with scholars based in Slovakia, Austria and Germany. Vladimı́r Leksa's co-authors include Hannes Stockinger, Bernd R. Binder, Herbert B. Schiller, Anna Ohradanova‐Repic, Václav Hořejšı́, Andreas Szekeres, Herbert B. Schiller, Ulrich H. Weidle, Samuel Godár and Wolfgang Paster and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Immunology and Circulation Research.

In The Last Decade

Vladimı́r Leksa

24 papers receiving 474 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vladimı́r Leksa Slovakia 15 247 115 87 67 60 24 479
Gunnel Östergren‐Lundén Sweden 10 298 1.2× 76 0.7× 58 0.7× 46 0.7× 21 0.3× 12 476
Samar Abdulkhalek Canada 14 412 1.7× 232 2.0× 84 1.0× 109 1.6× 15 0.3× 17 691
Giuseppina Federico Germany 15 477 1.9× 88 0.8× 98 1.1× 64 1.0× 15 0.3× 19 816
Hairong Chen China 14 233 0.9× 309 2.7× 62 0.7× 112 1.7× 20 0.3× 28 692
Magdalena B. Flak United Kingdom 13 255 1.0× 224 1.9× 32 0.4× 114 1.7× 71 1.2× 15 643
Atsushi Matsui Japan 9 166 0.7× 75 0.7× 92 1.1× 61 0.9× 20 0.3× 25 368
Dana P. Cook Belgium 11 135 0.5× 155 1.3× 29 0.3× 42 0.6× 27 0.5× 16 437
Guocheng He United States 9 396 1.6× 127 1.1× 43 0.5× 19 0.3× 36 0.6× 10 697
N Takami Japan 10 312 1.3× 77 0.7× 33 0.4× 60 0.9× 24 0.4× 13 535
Guirong Sun China 14 182 0.7× 61 0.5× 53 0.6× 131 2.0× 18 0.3× 32 587

Countries citing papers authored by Vladimı́r Leksa

Since Specialization
Citations

This map shows the geographic impact of Vladimı́r Leksa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vladimı́r Leksa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vladimı́r Leksa more than expected).

Fields of papers citing papers by Vladimı́r Leksa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vladimı́r Leksa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vladimı́r Leksa. The network helps show where Vladimı́r Leksa may publish in the future.

Co-authorship network of co-authors of Vladimı́r Leksa

This figure shows the co-authorship network connecting the top 25 collaborators of Vladimı́r Leksa. A scholar is included among the top collaborators of Vladimı́r Leksa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vladimı́r Leksa. Vladimı́r Leksa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Urban, Ján, et al.. (2025). The bronchoalveolar lavage fluid CD44 as a marker for pulmonary fibrosis in diffuse parenchymal lung diseases. Frontiers in Immunology. 15. 1479458–1479458. 2 indexed citations
3.
Ondrovičová, Gabriela, et al.. (2024). Lactoferrin Binds through Its N-Terminus to the Receptor-Binding Domain of the SARS-CoV-2 Spike Protein. Pharmaceuticals. 17(8). 1021–1021. 4 indexed citations
4.
Ohradanova‐Repic, Anna, et al.. (2023). Time to Kill and Time to Heal: The Multifaceted Role of Lactoferrin and Lactoferricin in Host Defense. Pharmaceutics. 15(4). 1056–1056. 34 indexed citations
5.
Ohradanova‐Repic, Anna, Rostislav Škrabana, Gábor Tajti, et al.. (2022). Blockade of TMPRSS2-mediated priming of SARS-CoV-2 by lactoferricin. Frontiers in Immunology. 13. 958581–958581. 13 indexed citations
6.
Urban, Ján, et al.. (2021). The Role of CX3CL1 and ADAM17 in Pathogenesis of Diffuse Parenchymal Lung Diseases. Diagnostics. 11(6). 1074–1074. 9 indexed citations
7.
Leitner, Judith, Karin Pfisterer, Vladimı́r Leksa, et al.. (2020). Differentiation and activation of human CD4 T cells is associated with a gradual loss of myelin and lymphocyte protein. European Journal of Immunology. 51(4). 848–863. 9 indexed citations
8.
Manka, Paul, et al.. (2018). Serum and urinary levels of CD222 in cancer: origin and diagnostic value. Neoplasma. 65(5). 762–768. 5 indexed citations
9.
Reiter, Michael, Rostislav Škrabana, Anna Ohradanova‐Repic, et al.. (2018). Lactoferrin is a natural inhibitor of plasminogen activation. Journal of Biological Chemistry. 293(22). 8600–8613. 30 indexed citations
11.
Machacek, Christian, Verena Supper, Vladimı́r Leksa, et al.. (2016). Folate Receptor β Regulates Integrin CD11b/CD18 Adhesion of a Macrophage Subset to Collagen. The Journal of Immunology. 197(6). 2229–2238. 16 indexed citations
12.
Schilter, Heidi, Carmen Z. Cantemir-Stone, Vladimı́r Leksa, et al.. (2015). The mannose-6-phosphate analogue, PXS64, inhibits fibrosis via TGF-β1 pathway in human lung fibroblasts. Immunology Letters. 165(2). 90–101. 15 indexed citations
13.
Pfisterer, Karin, Florian Förster, Wolfgang Paster, et al.. (2014). The Late Endosomal Transporter CD222 Directs the Spatial Distribution and Activity of Lck. The Journal of Immunology. 193(6). 2718–2732. 19 indexed citations
14.
Leksa, Vladimı́r, Karin Pfisterer, Gabriela Ondrovičová, et al.. (2012). Dissecting Mannose 6-Phosphate-Insulin-like Growth Factor 2 Receptor Complexes That Control Activation and Uptake of Plasminogen in Cells. Journal of Biological Chemistry. 287(27). 22450–22462. 15 indexed citations
15.
Leksa, Vladimı́r, Robert Loewe, Herbert B. Schiller, et al.. (2011). Soluble M6P/IGF2R Released by TACE Controls Angiogenesis via Blocking Plasminogen Activation. Circulation Research. 108(6). 676–685. 30 indexed citations
16.
Schiller, Herbert B., Florian Förster, Paul Eckerstorfer, et al.. (2009). Sequential Cooperation of CD2 and CD48 in the Buildup of the Early TCR Signalosome. The Journal of Immunology. 182(12). 7672–7680. 37 indexed citations
17.
Puxbaum, Verena, Barbara Svoboda, Vladimı́r Leksa, et al.. (2008). The mannose 6‐phosphate/insulin‐like growth factor II receptor restricts the tumourigenicity and invasiveness of squamous cell carcinoma cells. International Journal of Cancer. 124(11). 2559–2567. 18 indexed citations
18.
Schiller, Herbert B., Andreas Szekeres, Bernd R. Binder, Hannes Stockinger, & Vladimı́r Leksa. (2008). Mannose 6-Phosphate/Insulin-like Growth Factor 2 Receptor Limits Cell Invasion by Controlling αVβ3 Integrin Expression and Proteolytic Processing of Urokinase-type Plasminogen Activator Receptor. Molecular Biology of the Cell. 20(3). 745–756. 48 indexed citations
19.
Khunkaewla, Panida, Herbert B. Schiller, Wolfgang Paster, et al.. (2007). LFA-1-mediated leukocyte adhesion regulated by interaction of CD43 with LFA-1 and CD147. Molecular Immunology. 45(6). 1703–1711. 23 indexed citations
20.
Leksa, Vladimı́r, Samuel Godár, Marek Cebecauer, et al.. (2002). The N Terminus of Mannose 6-Phosphate/Insulin-like Growth Factor 2 Receptor in Regulation of Fibrinolysis and Cell Migration. Journal of Biological Chemistry. 277(43). 40575–40582. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026